These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 880745)
21. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055 [TBL] [Abstract][Full Text] [Related]
22. Contribution of the gene linked to the T cell receptor beta chain gene complex of NZW mice to the autoimmunity of (NZB x NZW)F1 mice. Hirose S; Tokushige K; Kinoshita K; Nozawa S; Saito J; Nishimura H; Shirai T Eur J Immunol; 1991 Mar; 21(3):823-6. PubMed ID: 1826267 [TBL] [Abstract][Full Text] [Related]
23. Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. Possible role of anti-idiotypic antibodies. Hahn BH; Ebling FM J Clin Invest; 1983 Jun; 71(6):1728-36. PubMed ID: 6223048 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic studies in New Zealand mice. VII. Successful androgen treatment of NZB/NZW F1 females of different ages. Melez KA; Boegel WA; Steinberg AD Arthritis Rheum; 1980 Jan; 23(1):41-7. PubMed ID: 7352943 [No Abstract] [Full Text] [Related]
25. Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice. Favoino E; Favia EI; Digiglio L; Racanelli V; Shoenfeld Y; Perosa F Clin Exp Immunol; 2014 Jan; 175(1):32-40. PubMed ID: 24112107 [TBL] [Abstract][Full Text] [Related]
26. Enhancing effect of H-2-linked NZW gene(s) on the autoimmune traits of (NZB X NZW)F1 mice. Hirose S; Nagasawa R; Sekikawa I; Hamaoki M; Ishida Y; Sato H; Shirai T J Exp Med; 1983 Jul; 158(1):228-33. PubMed ID: 6864161 [TBL] [Abstract][Full Text] [Related]
27. Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice. Hirose S; Ueda G; Noguchi K; Okada T; Sekigawa I; Sato H; Shirai T Eur J Immunol; 1986 Dec; 16(12):1631-3. PubMed ID: 2949983 [TBL] [Abstract][Full Text] [Related]
28. A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus. Ebling FM; Tsao BP; Singh RR; Sercarz E; Hahn BH Arthritis Rheum; 1993 Mar; 36(3):355-64. PubMed ID: 7680861 [TBL] [Abstract][Full Text] [Related]
29. Dissection of the effects of tumor necrosis factor-alpha and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE). Fujimura T; Hirose S; Jiang Y; Kodera S; Ohmuro H; Zhang D; Hamano Y; Ishida H; Furukawa S; Shirai T Int Immunol; 1998 Oct; 10(10):1467-72. PubMed ID: 9796913 [TBL] [Abstract][Full Text] [Related]
30. Immunologic studies of autoimmune disease in NZB-NZW F1 mice. I. Binding of fluorescein-labeled antinucleoside antibodies in lesions of lupus-like nephritis. Seegal BC; Accinni L; Andres GA; Beiser SM; Christian CL; Erlanger BF; Hsu K J Exp Med; 1969 Aug; 130(2):203-16. PubMed ID: 4183483 [TBL] [Abstract][Full Text] [Related]
31. Treatment of lupus nephritis in adult (NZB + NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens. Borel Y; Lewis RM; André-Schwartz J; Stollar BD; Diener E J Clin Invest; 1978 Feb; 61(2):276-86. PubMed ID: 304453 [TBL] [Abstract][Full Text] [Related]
32. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice. Reininger L; Winkler TH; Kalberer CP; Jourdan M; Melchers F; Rolink AG J Exp Med; 1996 Sep; 184(3):853-61. PubMed ID: 9064345 [TBL] [Abstract][Full Text] [Related]
33. [The effect of inducers of endogenous interferon on the course of an autoimmune process in F1 inbred NZB/NZW mice]. Nasonova VA; Balabanova RM; Pleskovskaia GN; Venikova MS; Poverennyĭ AM; Podgorodnichenko VK; Popova GA Vopr Virusol; 1990; 35(5):408-11. PubMed ID: 2267785 [No Abstract] [Full Text] [Related]
34. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. Gilkeson GS; Pippen AM; Pisetsky DS J Clin Invest; 1995 Mar; 95(3):1398-402. PubMed ID: 7883986 [TBL] [Abstract][Full Text] [Related]
35. The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice. Kotzin BL; Palmer E J Exp Med; 1987 May; 165(5):1237-51. PubMed ID: 3494806 [TBL] [Abstract][Full Text] [Related]
36. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice. Dong L; Ito S; Ishii KJ; Klinman DM Arthritis Rheum; 2005 Feb; 52(2):651-8. PubMed ID: 15692999 [TBL] [Abstract][Full Text] [Related]
37. Successful treatment of autoimmune disease in (NZB/NZW)F1 female mice by using fractionated total lymphoid irradiation. Slavin S Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5274-6. PubMed ID: 291944 [TBL] [Abstract][Full Text] [Related]
38. Extensively re-organized systemic lymph nodes provide a feasible environment for self-reactivity in lupus-prone NZB × NZW F1 mice. Kurosawa Y; Ozawa M; Kanda Y; Takeuchi A; Kawamura T; Narita I; Katakai T Int Immunol; 2017 Dec; 29(12):567-579. PubMed ID: 29202179 [TBL] [Abstract][Full Text] [Related]
39. (NZW x BXSB)F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction. Hang LM; Izui S; Dixon FJ J Exp Med; 1981 Jul; 154(1):216-21. PubMed ID: 7252427 [TBL] [Abstract][Full Text] [Related]
40. Effects of transgenic mixed-haplotype MHC class II molecules A alpha d A beta z on autoimmune disease in New Zealand mice. Nishimura H; Ishikawa S; Nozawa S; Awaji M; Saito J; Abe M; Tokushima M; Kimoto M; Akakura S; Tsurui H; Hirose S; Shirai T Int Immunol; 1996 Jun; 8(6):967-76. PubMed ID: 8671686 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]